首页 | 本学科首页   官方微博 | 高级检索  
     

正电子发射断层显像对肺癌诊断和分期的价值
引用本文:Zhu ZH,Zhou Q,Li LY,Cui RX,Cheng WY,Li YF. 正电子发射断层显像对肺癌诊断和分期的价值[J]. 中国医学科学院学报, 2001, 23(4): 364-368
作者姓名:Zhu ZH  Zhou Q  Li LY  Cui RX  Cheng WY  Li YF
作者单位:中国医学科学院中国协和医科大学协和医院核医学科PET中心 北京 100730
摘    要:目的 评价^18F脱氧葡萄糖(^18FDG)正电子发射断层(PET)显像对肺内占位病变诊断和肺癌分期的价值。方法 147例内病变患者,其中肺癌93例、肺转移癌15例、良性病变39例,共进行163次PDG PET显像。其中68例恶性和30例良性病例与相应的CT进行比较。结果 FDG PET对147例肺内占位病变良恶性鉴别的灵敏度为97.2%,特异性为89.7%,准确性为94.6%。93例肺癌患者中58例(62.4%)通过PET检查发现更多病灶,改变分期36例(38.7%)。98例PET显像与CT比较发现:两者符合仅39例(39.8%);PET发现病灶而CT未发现者29例(29.6%);CT发现病灶而PET代谢活性不高,通过随访诊断为良性病变30例(30.6%)。但CT在显示解剖结构方面明显优于PET。结论 FDG PET显像通过显示病变部位的葡萄糖代谢活性而对肺癌的诊断和分期有较大的价值,与CT精细的形态解剖结构结合可为临床诊断提供更多的信息。

关 键 词:肺癌 CT PET 诊断 分期
修稿时间:2001-02-25

Evaluation of positron emission tomography in diagnosing and staging of lung cancer
Zhu Z H,Zhou Q,Li L Y,Cui R X,Cheng W Y,Li Y F. Evaluation of positron emission tomography in diagnosing and staging of lung cancer[J]. Acta Academiae Medicinae Sinicae, 2001, 23(4): 364-368
Authors:Zhu Z H  Zhou Q  Li L Y  Cui R X  Cheng W Y  Li Y F
Affiliation:PET Center, PUMC Hospital, CAMS and PUMC, Beijing 100730, China. zhuzh@csc.pumch.ac.cn
Abstract:OBJECTIVE: To evaluate positron emission tomography (PET) in diagnosing and staging of lung cancer. METHODS: One hundred and forty-seven patients (93 with lung cancer, 15 with lung metastatic tumors, 39 with benign lesions) were involved in the study. 163 whole body examinations (twice in 12 cases and 3 times in 2 cases) were performed after injection of 18F-fluro-deoxy-glucose (18FDG) with a Siemens ECAT EXACT HR + PET system. The results of PET were compared with pathological diagnoses (112 cases), clinical follow-up (35 cases), CT (68 malignant and 30 benign cases), and other imaging diagnoses. RESULTS: For the 147 cases with lung lesions, the sensitivity, specificity, and accuracy of FDG PET in differentiating the malignant from the benign were 97.2%, 89.7%, and 94.6% respectively. For the 93 lung cancer cases, more lesions were detected by PET in 58 (62.4%) cases, and changed staging in 36 (38.7%). In the 98 cases examinations, PET positive findings were consistent with CT in 39 (39.8%) cases; PET detected more lesions than CT in 29 (29.6%) cases; the lesions detected by CT were negative or with low uptake in the PET images in 30 (30.6%) cases, and they were finally proved as benign by follow-up. However, CT provided better detailed anatomical structures of the lesions than PET, and image fusion should give more information about the lesions. CONCLUSIONS: FDG PET had advantages in diagnosing and staging of lung cancer by providing metabolic information of the lesions. Comparison and fusion of PET with CT will give much help to clinical diagnosis.
Keywords:
本文献已被 CNKI 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号